¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"unilateral hypertrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ.
  • asymmetric septal hypertrophy
    ºñ´ëμº Á߰ݺñ´ë(ÞªÓßöààõ ñḛ́ÝþÓÞ)
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ
  • asymmetric ventricular hypertrophy
    ºñ´ëμº ½É½Çºñ´ëÁõ.
  • atrial hypertrophy
    ½É¹æºñ´ë(ãýÛ®ÝþÓÞ).
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)(¡­îñí¡àÊÝþÓÞñø).
  • big heel =endemic hypertrophy of os calcis
    ºñÈÄ Á¾ºÎ(Ýþý§ñ¢Ý»), Á¾ºÎ Áö¹æ¼º ºñÈÄ(ñ¢Ý»ò¢Û°àõÝþý§), Å« µÚ²ÞÄ¡, À¯Ç༺ Á¾°ñÁ¾·ù(¡­ñ¢Íéðþ×»).
  • biventricular hypertrophy
    ¾ç(Ãø)½É½Çºñ´ë(å»[ö°]ãýãøÝþÓÞ).
  • biventricular hypertrophy
    ¾ç½É½Ç ºñ´ë
  • biventricular hypertrophy
    ¾ç(Ãø)½É½Çºñ´ë(å»ö°ãýãøÝþÓÞ).
  • cardiac hypertrophy
    ½É(Àå)ºñ´ë(ãýíôÞ¡ÓÞ).
  • cell,hypertrophy
    ºñÈÄ(Ýþý§)
  • clitoral hypertrophy
    À½ÇÙºñ´ë
  • combined ventricular hypertrophy
    º¹ÇÕ¼º ½É½Çºñ´ë.
  • compensatory hypertrophy
    ´ë»ó¼ººñ´ë(ÓÛßÁàõÝþÓÞ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
UNTS unilateral nevoid telangiectasia syndrome
URVD unilateral renovascular disease
USN ultrasonic nebulizer; unilateral spatial neglect
USO unilateral salpingo-oophorectomy
UTP unilateral tension pneumothorax; unshielded twisted pair; uridine triphosphate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DUSN Diffuse unilateral subacute neuroretinitis
UCLP Unilateral Cleft Lip and Palate
USN Unilateral Spatial Neglect
UL Unilateral labyrinthectomy
UNX Unilateral nephrectomy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tonsillar hypertrophy
    Æíµµ ºñ´ë
    ±¸°³ ÆíµµÀÇ ºñ´ë. ´ëü·Î ÀεΠÆíµµ, ¼³±Ù Æíµµ, À̰ü ÆíµµÀÇ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â °æ¿ì°¡ ¸¹´Ù. ½Å»ý¾Æ¿¡¼­´Â ±×´ÙÁö º¼ ¼ö ¾øÁö¸¸, ¿¬·É Áõ°¡¿Í ÇÔ²² Ä¿Á® ÇзɱⰡ µÇ¸é ÃÖ´ë·Î µÇ°í, »çÃá±â ÀÌÈÄ¿¡´Â ÅðÇà À§ÃàÇÑ´Ù. ÀÌ¿Í °°Àº ¿¬·É¿¡ µû¸¥ ¹ßÀ° ÇüÅÂÀÇ ¿øÀÎÀº ¾ÆÁ÷ ¹àÇôÁöÁö ¾Ê¾Ò´Âµ¥ ÀÌ ¹ßÀ° ÇüŰ¡ ºñÁ¤»óÀÎ °æ¿ì, ¿¬ÇÏ¿Í È£Èí¿¡ Àå¾Ö¸¦ ÃÊ·¡ÇÑ´Ù. Áõ»óÀº 3µµ·Î ±¸ºÐµÇ´Âµ¥, 1µµ´Â ±×´ÙÁö ½ÉÇÏÁö ¾ÊÀº °æ¿ì, 2µµ´Â ±¸°³±ÃÀ» ³Ñ¾î ±¸°³ Æíµµ°¡ Àεΰ­ ¼ÓÀ¸·Î ¾î´À Á¤µµ µ¹ÃâÇÑ °æ¿ì, 3µµ´Â Á¿ìÀÇ ±¸°³ Æíµµ°¡ ¼­·Î Á¢ÃËÇÒ Á¤µµ·Î ºñ´ëÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. 3µµÀÇ °æ¿ì, ¿Ü°úÀûÀ¸·Î ÀýÁ¦ÇØ¾ß ÇÒ Çʿ䰡 ÀÖ´Ù. ÀεΠÆíµµÀÇ ºñ´ë´Â ¾Æµ¥³ëÀ̵å Áõ½ÄÀ̶ó°í Çϴµ¥, ¾î¸°¾ÆÀÌ¿¡°Ô ¸¹°í ºñ È£ÈíÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. ¼³±Ù Æíµµ ºñ´ë´Â ¼ºÀο¡°Ô ¸¹´Ù.
  • true hypertrophy
    Áø¼º ºñ´ë
  • vicarious hypertrophy
    ´ë»ó¼º ºñ´ë
  • zone of hypertrophy
    ºñ´ëÃþ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
true hypertrophy An increase in size involving all the different tissues composing the part.
(05 Mar 2000)
false hypertrophy Increase in size of an organ or a part, due not to increase in size or number of the specific functional elements but to that of some other tissue, fatty or fibrous.
Synonym: false hypertrophy.
(05 Mar 2000)
left ventricular hypertrophy <radiology> Coarctation, aortic stenosis
(12 Dec 1998)
functional hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
lipomatous hypertrophy Nonencapsulated adipose tissue forming a lipoma-like mass, usually in the cardiac interatrial septum where it may cause arrhythmia and sudden death.
Synonym: lipomatous hypertrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á